Related by context. Frequent words. (Click for all words.) 77 Completes Enrollment 76 Presents Positive 74 Clinical Trial Results 72 Initiates Phase 71 Drug Candidate 71 Announces Initiation 71 Inc Therapeutic Competitors 71 Patient Enrollment 70 Phase III Clinical Trial 70 Reports Positive 70 Pivotal Phase III 70 Announces Presentation 70 Phase III Trial 69 Announces Positive 69 Preclinical Data 68 FDA Accepts 68 Receives FDA Clearance 68 Pivotal Trial 67 Inc. Nasdaq IMGN 67 Announces Publication 67 FDA Clears 67 Pivotal Phase 66 Announces Issuance 66 Receives Positive 66 Clinical Study 66 Pulmonary Arterial Hypertension 65 Patent Issued 65 Announces Successful Completion 65 Patent Covering 65 RNAi Therapeutics 65 Nasdaq ALTH 65 Achieves Milestone 64 PYMX 64 Chronic Hepatitis C 64 FDA Approves 64 Pirfenidone 64 Study Demonstrates 64 Shows Promise 64 R bortezomib 64 Receives Patent 64 Report companiesandmarkets.com adds 64 Well Tolerated 64 R sorafenib tablets 63 Positive Opinion 63 Exploit collaboration 63 Rexahn Pharmaceuticals 63 BPAX 63 NASDAQ SHPGY 63 NASDAQ CRXL 63 Updates Shareholders 63 Metastatic Melanoma 63 submitted Biologics License 63 Patients Treated 63 Updates Guidance 63 Metastatic Colorectal Cancer 63 FDA Orphan Drug 62 Epratuzumab 62 ACADIA Pharmaceuticals 62 Successful Completion 62 Chronic Lymphocytic Leukemia 62 Phase IIb trials 62 SAR# [004] 62 Monotherapy 62 IIa trial 61 Ofatumumab 61 Monoclonal Antibody 61 Provides Updates 61 Completes Initial 61 ALTH 61 AUXL 61 DVAX 61 VIA Pharmaceuticals 61 Closes Financing 61 Cancer Immunotherapy 61 Regains Compliance With 61 PHARM 61 Generic Version 61 Nasdaq VRTX 61 CRXX 61 Study Confirms 61 Cholesterol Drug 61 Finalizes Acquisition 61 Idera Pharmaceuticals 61 Clinical Trial 61 Skymark Research Initiates Independent 61 Nasdaq REGN 61 Panzem R 61 AEterna Zentaris Inc. 61 Receives Notice 61 Regains Compliance 61 Significantly Reduces 61 AVANIR Pharmaceuticals 61 Prostate Cancer Patients 60 Commence Trading 60 Updates Status 60 Receives Regulatory 60 Receives Approval 60 Receives CE 60 Phase Ib clinical 60 Diabetic Macular Edema 60 plc LSE AU